Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:myristates'
(id=6731367 ; fe=en:myristates ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1519 creation date=2017-06-21 touchdate=2025-04-24 01:23:09.000)
≈ 56 relations sortantes

  1. en:myristates -- r_associated #0: 42 / 1 -> en:o,o'-bismyristoyl thiamine disulfide
    n1=en:myristates | n2=en:o,o'-bismyristoyl thiamine disulfide | rel=r_associated | relid=0 | w=42
  2. en:myristates -- r_associated #0: 38 / 0.905 -> en:alpha-trifluoromethyltetradecanoic acid
    n1=en:myristates | n2=en:alpha-trifluoromethyltetradecanoic acid | rel=r_associated | relid=0 | w=38
  3. en:myristates -- r_associated #0: 36 / 0.857 -> chimie
    n1=en:myristates | n2=chimie | rel=r_associated | relid=0 | w=36
  4. en:myristates -- r_associated #0: 36 / 0.857 -> en:4-hydroxyphenethyl tetradecanoate
    n1=en:myristates | n2=en:4-hydroxyphenethyl tetradecanoate | rel=r_associated | relid=0 | w=36
  5. en:myristates -- r_associated #0: 35 / 0.833 -> en:2-n-myristoylamino-1-(4-nitrophenyl)-1,3-propandiol
    n1=en:myristates | n2=en:2-n-myristoylamino-1-(4-nitrophenyl)-1,3-propandiol | rel=r_associated | relid=0 | w=35
  6. en:myristates -- r_associated #0: 35 / 0.833 -> en:4-o-tetradecanoyl-2,3-dideoxyglucono-1,5-lactone
    n1=en:myristates | n2=en:4-o-tetradecanoyl-2,3-dideoxyglucono-1,5-lactone | rel=r_associated | relid=0 | w=35
  7. en:myristates -- r_associated #0: 35 / 0.833 -> en:diffusil care
    n1=en:myristates | n2=en:diffusil care | rel=r_associated | relid=0 | w=35
  8. en:myristates -- r_associated #0: 35 / 0.833 -> en:poisoning aspects
    n1=en:myristates | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=35
  9. en:myristates -- r_associated #0: 35 / 0.833 -> en:toxicity aspects
    n1=en:myristates | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=35
  10. en:myristates -- r_associated #0: 34 / 0.81 -> en:2-n-(tetradecylamino)-1-phenyl-1,3-propanediol
    n1=en:myristates | n2=en:2-n-(tetradecylamino)-1-phenyl-1,3-propanediol | rel=r_associated | relid=0 | w=34
  11. en:myristates -- r_associated #0: 34 / 0.81 -> en:3-dodecanoyltetradecanoic acid
    n1=en:myristates | n2=en:3-dodecanoyltetradecanoic acid | rel=r_associated | relid=0 | w=34
  12. en:myristates -- r_associated #0: 34 / 0.81 -> en:in urine
    n1=en:myristates | n2=en:in urine | rel=r_associated | relid=0 | w=34
  13. en:myristates -- r_associated #0: 32 / 0.762 -> en:beta-cryptoxanthin myristate
    n1=en:myristates | n2=en:beta-cryptoxanthin myristate | rel=r_associated | relid=0 | w=32
  14. en:myristates -- r_associated #0: 32 / 0.762 -> en:exposure as collected domain
    n1=en:myristates | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=32
  15. en:myristates -- r_associated #0: 32 / 0.762 -> en:metabolic aspects
    n1=en:myristates | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=32
  16. en:myristates -- r_associated #0: 31 / 0.738 -> chimie organique
    n1=en:myristates | n2=chimie organique | rel=r_associated | relid=0 | w=31
  17. en:myristates -- r_associated #0: 31 / 0.738 -> en:immunology aspects
    n1=en:myristates | n2=en:immunology aspects | rel=r_associated | relid=0 | w=31
  18. en:myristates -- r_associated #0: 31 / 0.738 -> en:in blood
    n1=en:myristates | n2=en:in blood | rel=r_associated | relid=0 | w=31
  19. en:myristates -- r_associated #0: 31 / 0.738 -> en:isopropyl myristate
    n1=en:myristates | n2=en:isopropyl myristate | rel=r_associated | relid=0 | w=31
  20. en:myristates -- r_associated #0: 31 / 0.738 -> en:mechanism of action qualifier
    n1=en:myristates | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=31
  21. en:myristates -- r_associated #0: 31 / 0.738 -> en:octadecyl myristate
    n1=en:myristates | n2=en:octadecyl myristate | rel=r_associated | relid=0 | w=31
  22. en:myristates -- r_associated #0: 31 / 0.738 -> en:taxonomic
    n1=en:myristates | n2=en:taxonomic | rel=r_associated | relid=0 | w=31
  23. en:myristates -- r_associated #0: 30 / 0.714 -> en:2-naphthylmyristate
    n1=en:myristates | n2=en:2-naphthylmyristate | rel=r_associated | relid=0 | w=30
  24. en:myristates -- r_associated #0: 30 / 0.714 -> en:chemical aspects
    n1=en:myristates | n2=en:chemical aspects | rel=r_associated | relid=0 | w=30
  25. en:myristates -- r_associated #0: 30 / 0.714 -> en:n-tetradecane
    n1=en:myristates | n2=en:n-tetradecane | rel=r_associated | relid=0 | w=30
  26. en:myristates -- r_associated #0: 29 / 0.69 -> en:11-hydroxytetradecanoic acid
    n1=en:myristates | n2=en:11-hydroxytetradecanoic acid | rel=r_associated | relid=0 | w=29
  27. en:myristates -- r_associated #0: 29 / 0.69 -> en:12-hydroxytetradecanoic acid
    n1=en:myristates | n2=en:12-hydroxytetradecanoic acid | rel=r_associated | relid=0 | w=29
  28. en:myristates -- r_associated #0: 29 / 0.69 -> en:chemical synthesis
    n1=en:myristates | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=29
  29. en:myristates -- r_associated #0: 29 / 0.69 -> en:contraindications aspect
    n1=en:myristates | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=29
  30. en:myristates -- r_associated #0: 29 / 0.69 -> en:in cerebrospinal fluid
    n1=en:myristates | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=29
  31. en:myristates -- r_associated #0: 29 / 0.69 -> en:myristate
    n1=en:myristates | n2=en:myristate | rel=r_associated | relid=0 | w=29
  32. en:myristates -- r_associated #0: 29 / 0.69 -> en:tetradecanal
    n1=en:myristates | n2=en:tetradecanal | rel=r_associated | relid=0 | w=29
  33. en:myristates -- r_associated #0: 28 / 0.667 -> en:1-sulfate-3-myristoyl-5-pentadecylbenzene
    n1=en:myristates | n2=en:1-sulfate-3-myristoyl-5-pentadecylbenzene | rel=r_associated | relid=0 | w=28
  34. en:myristates -- r_associated #0: 28 / 0.667 -> en:13-methyl-n-(2-phenylethyl)tetradecanamide
    n1=en:myristates | n2=en:13-methyl-n-(2-phenylethyl)tetradecanamide | rel=r_associated | relid=0 | w=28
  35. en:myristates -- r_associated #0: 28 / 0.667 -> en:2-(n-myristoylamino)-1-phenyl-1-propanol
    n1=en:myristates | n2=en:2-(n-myristoylamino)-1-phenyl-1-propanol | rel=r_associated | relid=0 | w=28
  36. en:myristates -- r_associated #0: 28 / 0.667 -> en:agonists
    n1=en:myristates | n2=en:agonists | rel=r_associated | relid=0 | w=28
  37. en:myristates -- r_associated #0: 28 / 0.667 -> en:analysis aspect
    n1=en:myristates | n2=en:analysis aspect | rel=r_associated | relid=0 | w=28
  38. en:myristates -- r_associated #0: 28 / 0.667 -> en:aspects of adverse effects
    n1=en:myristates | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=28
  39. en:myristates -- r_associated #0: 28 / 0.667 -> en:myristic acid
    n1=en:myristates | n2=en:myristic acid | rel=r_associated | relid=0 | w=28
  40. en:myristates -- r_associated #0: 28 / 0.667 -> en:myristic acids
    n1=en:myristates | n2=en:myristic acids | rel=r_associated | relid=0 | w=28
  41. en:myristates -- r_associated #0: 28 / 0.667 -> en:n-(3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide
    n1=en:myristates | n2=en:n-(3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide | rel=r_associated | relid=0 | w=28
  42. en:myristates -- r_associated #0: 28 / 0.667 -> en:o,o'-detetradecanoyl-n-(alpha-trimethylammonioacetyl)diethanolamine chloride
    n1=en:myristates | n2=en:o,o'-detetradecanoyl-n-(alpha-trimethylammonioacetyl)diethanolamine chloride | rel=r_associated | relid=0 | w=28
  43. en:myristates -- r_associated #0: 28 / 0.667 -> en:standards characteristics
    n1=en:myristates | n2=en:standards characteristics | rel=r_associated | relid=0 | w=28
  44. en:myristates -- r_associated #0: 27 / 0.643 -> en:1,2-dimyristoyl-3-trimethylammonium propane
    n1=en:myristates | n2=en:1,2-dimyristoyl-3-trimethylammonium propane | rel=r_associated | relid=0 | w=27
  45. en:myristates -- r_associated #0: 27 / 0.643 -> en:aspects of radiation effects
    n1=en:myristates | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=27
  46. en:myristates -- r_associated #0: 27 / 0.643 -> en:ethyl myristate
    n1=en:myristates | n2=en:ethyl myristate | rel=r_associated | relid=0 | w=27
  47. en:myristates -- r_associated #0: 27 / 0.643 -> en:historical aspects qualifier
    n1=en:myristates | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=27
  48. en:myristates -- r_associated #0: 27 / 0.643 -> en:polyethylene glycol myristate
    n1=en:myristates | n2=en:polyethylene glycol myristate | rel=r_associated | relid=0 | w=27
  49. en:myristates -- r_associated #0: 27 / 0.643 -> en:prevasore
    n1=en:myristates | n2=en:prevasore | rel=r_associated | relid=0 | w=27
  50. en:myristates -- r_associated #0: 27 / 0.643 -> en:therapeutic use - qualifier
    n1=en:myristates | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=27
  51. en:myristates -- r_associated #0: 26 / 0.619 -> en:pharmacokinetic aspects
    n1=en:myristates | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=26
  52. en:myristates -- r_associated #0: 15 / 0.357 -> en:organic chemistry
    n1=en:myristates | n2=en:organic chemistry | rel=r_associated | relid=0 | w=15
  53. en:myristates -- r_associated #0: 3 / 0.071 -> en:organic chemical
    n1=en:myristates | n2=en:organic chemical | rel=r_associated | relid=0 | w=3
  54. en:myristates -- r_associated #0: 3 / 0.071 -> produit chimique organique
    n1=en:myristates | n2=produit chimique organique | rel=r_associated | relid=0 | w=3
  55. en:myristates -- r_associated #0: 2 / 0.048 -> en:chemical
    n1=en:myristates | n2=en:chemical | rel=r_associated | relid=0 | w=2
  56. en:myristates -- r_associated #0: 2 / 0.048 -> produit chimique
    n1=en:myristates | n2=produit chimique | rel=r_associated | relid=0 | w=2
≈ 54 relations entrantes

  1. en:octadecyl myristate --- r_associated #0: 39 --> en:myristates
    n1=en:octadecyl myristate | n2=en:myristates | rel=r_associated | relid=0 | w=39
  2. en:1-sulfate-3-myristoyl-5-pentadecylbenzene --- r_associated #0: 38 --> en:myristates
    n1=en:1-sulfate-3-myristoyl-5-pentadecylbenzene | n2=en:myristates | rel=r_associated | relid=0 | w=38
  3. en:2-n-(tetradecylamino)-1-phenyl-1,3-propanediol --- r_associated #0: 35 --> en:myristates
    n1=en:2-n-(tetradecylamino)-1-phenyl-1,3-propanediol | n2=en:myristates | rel=r_associated | relid=0 | w=35
  4. en:beta-cryptoxanthin myristate --- r_associated #0: 35 --> en:myristates
    n1=en:beta-cryptoxanthin myristate | n2=en:myristates | rel=r_associated | relid=0 | w=35
  5. en:12-hydroxytetradecanoic acid --- r_associated #0: 34 --> en:myristates
    n1=en:12-hydroxytetradecanoic acid | n2=en:myristates | rel=r_associated | relid=0 | w=34
  6. en:2-naphthylmyristate --- r_associated #0: 34 --> en:myristates
    n1=en:2-naphthylmyristate | n2=en:myristates | rel=r_associated | relid=0 | w=34
  7. en:o,o'-bismyristoyl thiamine disulfide --- r_associated #0: 34 --> en:myristates
    n1=en:o,o'-bismyristoyl thiamine disulfide | n2=en:myristates | rel=r_associated | relid=0 | w=34
  8. en:o,o'-detetradecanoyl-n-(alpha-trimethylammonioacetyl)diethanolamine chloride --- r_associated #0: 34 --> en:myristates
    n1=en:o,o'-detetradecanoyl-n-(alpha-trimethylammonioacetyl)diethanolamine chloride | n2=en:myristates | rel=r_associated | relid=0 | w=34
  9. en:2-(n-myristoylamino)-1-phenyl-1-propanol --- r_associated #0: 32 --> en:myristates
    n1=en:2-(n-myristoylamino)-1-phenyl-1-propanol | n2=en:myristates | rel=r_associated | relid=0 | w=32
  10. en:2-n-myristoylamino-1-(4-nitrophenyl)-1,3-propandiol --- r_associated #0: 32 --> en:myristates
    n1=en:2-n-myristoylamino-1-(4-nitrophenyl)-1,3-propandiol | n2=en:myristates | rel=r_associated | relid=0 | w=32
  11. en:mechanism of action qualifier --- r_associated #0: 32 --> en:myristates
    n1=en:mechanism of action qualifier | n2=en:myristates | rel=r_associated | relid=0 | w=32
  12. en:11-hydroxytetradecanoic acid --- r_associated #0: 31 --> en:myristates
    n1=en:11-hydroxytetradecanoic acid | n2=en:myristates | rel=r_associated | relid=0 | w=31
  13. en:4-o-tetradecanoyl-2,3-dideoxyglucono-1,5-lactone --- r_associated #0: 31 --> en:myristates
    n1=en:4-o-tetradecanoyl-2,3-dideoxyglucono-1,5-lactone | n2=en:myristates | rel=r_associated | relid=0 | w=31
  14. en:pharmacokinetic aspects --- r_associated #0: 31 --> en:myristates
    n1=en:pharmacokinetic aspects | n2=en:myristates | rel=r_associated | relid=0 | w=31
  15. en:standards characteristics --- r_associated #0: 31 --> en:myristates
    n1=en:standards characteristics | n2=en:myristates | rel=r_associated | relid=0 | w=31
  16. en:chemical synthesis --- r_associated #0: 30 --> en:myristates
    n1=en:chemical synthesis | n2=en:myristates | rel=r_associated | relid=0 | w=30
  17. en:ethyl myristate --- r_associated #0: 30 --> en:myristates
    n1=en:ethyl myristate | n2=en:myristates | rel=r_associated | relid=0 | w=30
  18. en:prevasore --- r_associated #0: 30 --> en:myristates
    n1=en:prevasore | n2=en:myristates | rel=r_associated | relid=0 | w=30
  19. en:agonists --- r_associated #0: 29 --> en:myristates
    n1=en:agonists | n2=en:myristates | rel=r_associated | relid=0 | w=29
  20. en:myristate --- r_associated #0: 29 --> en:myristates
    n1=en:myristate | n2=en:myristates | rel=r_associated | relid=0 | w=29
  21. en:polyethylene glycol myristate --- r_associated #0: 29 --> en:myristates
    n1=en:polyethylene glycol myristate | n2=en:myristates | rel=r_associated | relid=0 | w=29
  22. en:therapeutic use - qualifier --- r_associated #0: 29 --> en:myristates
    n1=en:therapeutic use - qualifier | n2=en:myristates | rel=r_associated | relid=0 | w=29
  23. en:4-hydroxyphenethyl tetradecanoate --- r_associated #0: 28 --> en:myristates
    n1=en:4-hydroxyphenethyl tetradecanoate | n2=en:myristates | rel=r_associated | relid=0 | w=28
  24. en:n-(3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide --- r_associated #0: 28 --> en:myristates
    n1=en:n-(3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide | n2=en:myristates | rel=r_associated | relid=0 | w=28
  25. en:13-methyl-n-(2-phenylethyl)tetradecanamide --- r_associated #0: 27 --> en:myristates
    n1=en:13-methyl-n-(2-phenylethyl)tetradecanamide | n2=en:myristates | rel=r_associated | relid=0 | w=27
  26. en:aspects of radiation effects --- r_associated #0: 27 --> en:myristates
    n1=en:aspects of radiation effects | n2=en:myristates | rel=r_associated | relid=0 | w=27
  27. en:immunology aspects --- r_associated #0: 27 --> en:myristates
    n1=en:immunology aspects | n2=en:myristates | rel=r_associated | relid=0 | w=27
  28. en:metabolic aspects --- r_associated #0: 27 --> en:myristates
    n1=en:metabolic aspects | n2=en:myristates | rel=r_associated | relid=0 | w=27
  29. en:myristic acids --- r_associated #0: 27 --> en:myristates
    n1=en:myristic acids | n2=en:myristates | rel=r_associated | relid=0 | w=27
  30. en:n-tetradecane --- r_associated #0: 27 --> en:myristates
    n1=en:n-tetradecane | n2=en:myristates | rel=r_associated | relid=0 | w=27
  31. en:3-dodecanoyltetradecanoic acid --- r_associated #0: 26 --> en:myristates
    n1=en:3-dodecanoyltetradecanoic acid | n2=en:myristates | rel=r_associated | relid=0 | w=26
  32. en:alpha-trifluoromethyltetradecanoic acid --- r_associated #0: 26 --> en:myristates
    n1=en:alpha-trifluoromethyltetradecanoic acid | n2=en:myristates | rel=r_associated | relid=0 | w=26
  33. en:diffusil care --- r_associated #0: 26 --> en:myristates
    n1=en:diffusil care | n2=en:myristates | rel=r_associated | relid=0 | w=26
  34. en:tetradecanal --- r_associated #0: 26 --> en:myristates
    n1=en:tetradecanal | n2=en:myristates | rel=r_associated | relid=0 | w=26
  35. en:in cerebrospinal fluid --- r_associated #0: 25 --> en:myristates
    n1=en:in cerebrospinal fluid | n2=en:myristates | rel=r_associated | relid=0 | w=25
  36. en:myristic acid --- r_associated #0: 25 --> en:myristates
    n1=en:myristic acid | n2=en:myristates | rel=r_associated | relid=0 | w=25
  37. en:exposure as collected domain --- r_associated #0: 24 --> en:myristates
    n1=en:exposure as collected domain | n2=en:myristates | rel=r_associated | relid=0 | w=24
  38. chimie --- r_associated #0: 20 --> en:myristates
    n1=chimie | n2=en:myristates | rel=r_associated | relid=0 | w=20
  39. chimie organique --- r_associated #0: 20 --> en:myristates
    n1=chimie organique | n2=en:myristates | rel=r_associated | relid=0 | w=20
  40. en:1,2-dimyristoyl-3-trimethylammonium propane --- r_associated #0: 20 --> en:myristates
    n1=en:1,2-dimyristoyl-3-trimethylammonium propane | n2=en:myristates | rel=r_associated | relid=0 | w=20
  41. en:analysis aspect --- r_associated #0: 20 --> en:myristates
    n1=en:analysis aspect | n2=en:myristates | rel=r_associated | relid=0 | w=20
  42. en:aspects of adverse effects --- r_associated #0: 20 --> en:myristates
    n1=en:aspects of adverse effects | n2=en:myristates | rel=r_associated | relid=0 | w=20
  43. en:chemical aspects --- r_associated #0: 20 --> en:myristates
    n1=en:chemical aspects | n2=en:myristates | rel=r_associated | relid=0 | w=20
  44. en:contraindications aspect --- r_associated #0: 20 --> en:myristates
    n1=en:contraindications aspect | n2=en:myristates | rel=r_associated | relid=0 | w=20
  45. en:historical aspects qualifier --- r_associated #0: 20 --> en:myristates
    n1=en:historical aspects qualifier | n2=en:myristates | rel=r_associated | relid=0 | w=20
  46. en:in blood --- r_associated #0: 20 --> en:myristates
    n1=en:in blood | n2=en:myristates | rel=r_associated | relid=0 | w=20
  47. en:in urine --- r_associated #0: 20 --> en:myristates
    n1=en:in urine | n2=en:myristates | rel=r_associated | relid=0 | w=20
  48. en:isopropyl myristate --- r_associated #0: 20 --> en:myristates
    n1=en:isopropyl myristate | n2=en:myristates | rel=r_associated | relid=0 | w=20
  49. en:poisoning aspects --- r_associated #0: 20 --> en:myristates
    n1=en:poisoning aspects | n2=en:myristates | rel=r_associated | relid=0 | w=20
  50. en:taxonomic --- r_associated #0: 20 --> en:myristates
    n1=en:taxonomic | n2=en:myristates | rel=r_associated | relid=0 | w=20
  51. en:toxicity aspects --- r_associated #0: 20 --> en:myristates
    n1=en:toxicity aspects | n2=en:myristates | rel=r_associated | relid=0 | w=20
  52. taxinomique --- r_associated #0: 10 --> en:myristates
    n1=taxinomique | n2=en:myristates | rel=r_associated | relid=0 | w=10
  53. Chimie Organique --- r_associated #0: 5 --> en:myristates
    n1=Chimie Organique | n2=en:myristates | rel=r_associated | relid=0 | w=5
  54. Chimie organique --- r_associated #0: 5 --> en:myristates
    n1=Chimie organique | n2=en:myristates | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr